Both the Pfizer and Moderna vaccines work by training our immune systems to recognize a specific version of the viral spike protein. The version of the spike protein used by the vaccines was designed to match that of the old virus, not that of the B.1.1.7 virus.
Despite the Oxford vaccine having lower overall effectiveness than the Pfizer or Moderna vaccines—at least at this interim stage—there are other success factors to consider. Safety is one, and the Oxford vaccine is so far reported to have a good safety record with no serious side-effects.
Scientists from the HIV Prevention Trials Network recently found that a PrEP regimen of long-acting cabotegravir (CAB LA) injections once every eight weeks was better than the daily tablet used for HIV prevention.
Before joining KBC as MD, Dr Naim Bilal served as the acting director of Information in the Republic under the Ministry of ICT, where he was honoured with a stint as acting PS for the State Department of Broadcasting and Telecommunications in December 2018.
In 2010, at a corner of a 5 square foot open office off Ngong road, 25-year-old Samantha Siyieyio Kipury sat alone, her courage spilling over, filling the empty space around her. Her life had just taken a trajectory that would propel her career in the media industry in Kenya
Dr Habil Olaka was appointed as Chief Executive Officer of the Kenya Bankers Association (KBA) in October 2010. Since then, Habil has been responsible for the strategic direction of the Association, covering industry advocacy, development and sustainability.
Rebecca Mbithi was appointed in mid-2018 and immediately shook the banking industry with her sterling performance.
Jane Karuku is a dynamic business leader, with strong management, marketing and global branding experience spanning over 25 years.
Since the new board’s appointment, Kenya Power has since July this year connected 140,000 new customers against a target of 125,000 despite the Covid-19 pandemic, which had slowed down activities of the firms due to the lockdowns and the need for social distancing.
Dr Githinji Gitahi is currently one of the most distinguished thought leaders in the healthcare industry and policy, a space he demonstrated his acumen and vision since the advent of the Covid-19 pandemic.
© 2025 All rights reserved, The Knowledge Warehouse Limited
Terms & Conditions Apply
